Page last updated: 2024-10-31

mianserin and Atherosclerotic Parkinsonism

mianserin has been researched along with Atherosclerotic Parkinsonism in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research Excerpts

ExcerptRelevanceReference
"Rats treated with haloperidol at doses of 0."1.37Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats. ( Haleem, DJ; Shireen, E, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shireen, E1
Haleem, DJ1
Korsgaard, S1
Friis, T1

Trials

1 trial available for mianserin and Atherosclerotic Parkinsonism

ArticleYear
Effects of mianserin in neuroleptic-induced parkinsonism.
    Psychopharmacology, 1986, Volume: 88, Issue:1

    Topics: Adult; Aged; Antipsychotic Agents; Dibenzazepines; Humans; Male; Mianserin; Middle Aged; Parasympath

1986

Other Studies

1 other study available for mianserin and Atherosclerotic Parkinsonism

ArticleYear
Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats.
    Pakistan journal of pharmaceutical sciences, 2011, Volume: 24, Issue:1

    Topics: Animals; Antipsychotic Agents; Catalepsy; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Ha

2011